Xeomin is one of four neuromodulators offered at Arkatiea Aesthetics & Wellness, alongside Botox, Jeuveau, and Daxxify. It's often described as the "purified" or "naked" option in the lineup — a nickname that actually points to a real, meaningful difference in how it's made.
What Makes Xeomin Different
Xeomin's active ingredient is incobotulinumtoxinA, a highly purified botulinum toxin type A. According to its FDA prescribing information, Xeomin is free of the accessory (complexing) proteins found in some other botulinum toxin products, and its potency units are specific to the product rather than interchangeable with other toxins. This manufacturing distinction is where the "naked toxin" description comes from — it's not marketing language, it's a real structural difference confirmed in the FDA label itself.
There's also a practical, real-world reason this matters to some patients. Complexing proteins have been studied as one possible contributor to the body building neutralizing antibodies against a toxin over repeated treatments, which can reduce how well it works over time. A trade press report on Xeomin's most recent FDA approval noted that complexing-protein-free formulations are of interest because just over 1 in 3 toxin users in one survey reported lessening effects from other toxin treatments over time — a pattern some providers associate with antibody formation. This is why Xeomin is often discussed as an option for patients who feel their usual toxin "isn't working like it used to."
What It's FDA-Approved to Treat
Xeomin was first FDA-approved in July 2011 for moderate to severe glabellar (frown) lines, based on two multicenter U.S. clinical trials involving 547 healthy adults. More recently, a company announcement confirmed that Xeomin became the first and only FDA-approved neurotoxin for the simultaneous treatment of forehead lines, frown lines, and crow's feet together, expanding on its original single-area approval.
Onset and Duration
According to the FDA label, the median first onset of Xeomin's effect occurs within seven days of injection, with a typical duration of up to three months — though the agency notes effects may last significantly longer or shorter for individual patients. One additional practical advantage noted by an early-adopting dermatologist: unlike some other formulations, Xeomin doesn't require refrigeration before reconstitution, which can simplify storage for the practices that carry it.
Who Xeomin Is a Good Fit For
Xeomin tends to come up most often for two kinds of patients: those interested in treating the forehead, frown lines, and crow's feet together in one formulation, and those who've noticed a favorite toxin "isn't working like it used to" after years of regular treatment. Neither is a guarantee — individual response always varies — but both are legitimate, well-documented reasons providers bring Xeomin into the conversation.
Where Arkatiea Fits In
Arkatiea Aesthetics & Wellness offers Xeomin as part of a full neuromodulator lineup that also includes Botox, Jeuveau, and Daxxify — so your consultation with Katie Redburn, RN can match the right formulation to your goals and history rather than offering just one option. Treatments are performed under the medical oversight of Hoder Independent Medical Consulting, PC.
Curious whether Xeomin or another neuromodulator is the right fit for you? Call 816-442-5520 or book a consultation online.